BIONEERCORPORATION Logo

BIONEERCORPORATION

Provides molecular biology tools & diagnostic kits for research and clinical applications.

064550 | KO

Overview

Corporate Details

ISIN(s):
KR7064550007
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 71 (주)바이오니아 글로벌센터, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1992, Bioneer Corporation is a biotechnology company specializing in molecular biology products and technologies. The company develops, manufactures, and supplies a comprehensive portfolio for the life sciences and molecular diagnostics (MDx) markets. Its core offerings include proprietary MDx systems and diagnostic kits for various infectious diseases, such as SARS-CoV-2, HIV, HBV, and HCV. Bioneer also provides a wide array of molecular biology reagents, gene synthesis services, PCR systems, and recombinant proteins. A key area of innovation is in laboratory instrumentation, including its patented AccuLoader™ precision device for automated sample handling. The company serves research, clinical, and industrial customers, providing a platform for disease prevention, diagnosis, and treatment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-06-18 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-06-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-30 00:00
Regulatory Filings
소속부변경
Korean 3.6 KB
2025-04-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.0 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 21.3 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 644.0 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 123.8 KB
2025-03-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all BIONEERCORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIONEERCORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIONEERCORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Gelteq Ltd Logo
Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.
United States of America
GELS
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea
082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea
229000
GENEDRIVE PLC Logo
Develops rapid, point-of-care genetic tests for time-critical healthcare to personalize medicine.
United Kingdom
GDR
GENELUX Corp Logo
Developing oncolytic viral immunotherapies for difficult-to-treat cancers using a vaccinia virus.
United States of America
GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea
109820
Generation Bio Co. Logo
Developing siRNA genetic medicines via targeted nanoparticles for autoimmune diseases.
United States of America
GBIO
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea
095700
Genfit S.A. Logo
Biopharma developing therapeutics and diagnostics for rare and life-threatening liver diseases.
United States of America
GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye
GENIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.